Company profile for Novotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Novotech has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotechnology companies. Novotech was established in 1996, with offices in 11 locations across the region, and site partnerships with major health institutions. Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regul...
Novotech has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotechnology companies. Novotech was established in 1996, with offices in 11 locations across the region, and site partnerships with major health institutions. Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
Novotech (Australia) Pty Limited Level 3, 235 Pyrmont Street Australia
Telephone
Telephone
+61 2 8569 1400
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251030722919/en/Novotech-Maps-Global-Growth-in-Radiopharmaceutical-Trials

BUSINESSWIRE
30 Oct 2025

https://www.businesswire.com/news/home/20250828998660/en/Novotech-Supports-Groundbreaking-Approval-of-Anlotinib-Combination-Therapy-for-Advanced-Soft-Tissue-Sarcoma

BUSINESSWIRE
28 Aug 2025

https://www.businesswire.com/news/home/20250729762112/en/Novotech-Awarded-Veeva-Hero-Award-at-2025-Veeva-RD-and-Quality-Summit

BUSINESSWIRE
29 Jul 2025

https://www.businesswire.com/news/home/20250717625155/en/Novotech-Report-How-In-Vivo-CAR-T-May-Reshape-Cell-Therapy-Economics

BUSINESSWIRE
17 Jul 2025

https://www.prnewswire.com/news-releases/novotech-earns-frost--sullivans-2025-global-company-of-the-year-recognition-for-excellence-in-biotech-clinical-research-services-302497223.html

PR NEWSWIRE
03 Jul 2025

https://www.businesswire.com/news/home/20250703950144/en/Frost-Sullivan-Recognizes-Novotech-as-2025-Global-Biotech-CRO-Company-of-the-Year

BUSINESSWIRE
03 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty